Bio-Techne, Kantaro Biosciences to produce COVID-19 serology test

Bio-Techne (NSDQ:TECH) and Kantaro Biosciences announced a partnership to manufacture and distribute COVID-19 serology tests.

Kantaro, a commercial affiliate of the Mount Sinai Health System in New York, will collaborate with Bio-Techne to develop a test kit based on the Mount Sinai-developed coronavirus test and scale the manufacturing and distribution of those kits. The companies formed a joint commercialization and distribution team to support the rapid distribution of the assay.